Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. UBS analyst Trung Huynh maintained a Neutral rating and raised the price target from $24 ...

Its dividend: The stock recently yielded a whopping 7.3%. That's hard to beat and will generate around $730 for every $10,000 ...

This comprehensive analysis examines Pfizer’s current position ... with InvestingPro data showing a robust gross profit margin of 74.4% and an attractive dividend yield of 7.38%. The company has ...

Pfizer’s current 7.5% dividend yield undeniably offers an excellent income component for investment portfolios. This payout is backed by a history of consistent growth and, importantly, by the ...

The 10-year T-note yield Tuesday rose +2 bp to 4.48% ... Dollar Tree (DLTR) closed up more than +4% after BWG Global upgraded the stock to positive from mixed. Pfizer (PFE) closed up more than +2% ...

So, is Pfizer's 7.63% dividend yield worth the effort? If I base my decision solely on a first level analysis of its past, I would say NO. Yet, investment is always about the future, not the past ...

This comprehensive analysis delves into Pfizer's current position ... impressive 69.78% gross profit margin and significant dividend yield of 6.46%. Want deeper insights into Pfizer's financial ...

That said, investing in dividend stocks can be more complex than it seems, requiring thorough analysis ... yield of 6.47%, as recorded on January 5. Parnassus Investments highlighted Pfizer ...